Navigation Links
Senetek PLC Announces 2009 Annual General Meeting Voting Results
Date:12/15/2009

NAPA, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization of technologies that target the science of healthy aging, today announced that shareholders had approved all three resolutions that the Company had proposed at the Annual General Meeting of Shareholders held on December 14, 2009. Voting results were as follows:




    Description of            Votes        Votes         Votes         Non-
     Matter                    For        Against       Withheld      Votes
    --------------            -----       -------       --------      -----

    Election of  Kerry
     Dukes as Director      6,165,331    1,363,208       71,963      45,300
    Receipt of Annual
     Accounts for 2008
     with Directors'
     Report, auditors'
     report on those
     accounts and
     approve the last
     Directors'
     remuneration
     report                 6,717,147      795,815       87,540      45,300
    Appointment of
     Macias Gini &
     O'Connell LLP and
     BDO Stoy Hayward
     as the Company's
     independent
     auditors for 2009      6,663,843      796,173      140,486      45,300



"We are pleased with the results of the voting and we thank our shareholders for their support" stated Frank J. Massino, Senetek Chairman and CEO.

Senetek PLC recently announced the hiring of Miller Tabak + Co., LLC as financial and strategic advisors. The Board has retained the firm to evaluate the Company's technology and business model and to make recommendations on the development of a plan that will benefit shareholders. As a result of this evaluation, Miller Tabak has made the following recommendations:

  • Consider changing the focus and direction of the Company and the current business model;
  • Identify potential business partners for merger and/or acquisition;
  • Raise additional capital.

The Company is currently in discussions with multiple investors and potential partners, however there is no assurance that these discussions will result in a completed transaction.

About Senetek PLC: Senetek PLC (OTCBB:SNKTY) is a Life Sciences company engaged in the research, development and commercialization of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology, most recently resulting in the development of kinetin, the active ingredient in the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's websites -- www.Senetekplc.com, www.Pyratine6.com and www.PyratineXR.com -- or call 877-SENETEK (United States and Canada) or 707-259-6278 (International Locations).

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2008 and subsequent Quarterly Reports on Form 10-Q. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.

SOURCE Senetek PLC


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Senetek Implements New Corporate Communication Policy
2. Senetek PLC Reports Second Quarter 2009 Financial Results
3. Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany
4. Senetek PLC Reports First Quarter 2009 Financial Results
5. Senetek PLC Reports 2008 Financial Results
6. Dynamics Group AG Publishes Research Report on Senetek
7. Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited
8. Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
9. Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
10. Senetek PLC Announces Key Personnel Appointments
11. Senetek PLC Reports 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Donor Network West, the federally-designated organ, ... announced the future opening of a CLIA certified dedicated laboratory in northern California ... determine the suitability of potential organ and tissue donors. This partnership will ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the ... HIV, reports Leslie Norins, MD, PhD. He says investigating this possibility, is ... Zika virus and in new infections with HIV. , His findings appear ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... imaging core lab with extensive therapeutic experience and operational excellence in oncology clinical ... immuno-oncology clinical trial for the treatment of non-small cell lung cancer and small ...
(Date:3/22/2017)... OK (PRWEB) , ... March 22, 2017 , ... ... insurance and financial planning services to regional families and business owners, is joining ... support to young people in the area. , A growing number of Oklahoma ...
(Date:3/22/2017)... ... March 22, 2017 , ... College basketball surges to its peak ... for recruiting – that is, recruiting people to be foster parents. Through a televised ... who are in foster care due to abuse, neglect and other family challenges. People ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 TFS is ... and Mr. Ed Tumaian , two global executive positions in ... be joining the Operational Leadership Team and will report to Dr. ... ... comes to TFS with 10 years of medical and scientific expertise ...
(Date:3/22/2017)... ROCKVILLE, Md. , March 22, 2017 ... that should be important to those following the industry.  This ... point-of-care (POC) RSV test, and the POC testing market ... grow. An Alere subsidiary is facing a legal battle ... Meanwhile, Beckman Coulter launched a new chemistry ...
(Date:3/22/2017)... CLARA, Calif. , March 22, 2017 /PRNewswire/ ... cardiology  solutions segment, Frost & Sullivan recognizes GE ... Company of the Year Award. GE Healthcare,s strategy ... end-to-end cardiac solutions has allowed it to effectively ... cardiac monitoring products space. In addition to aiding ...
Breaking Medicine Technology: